Ulka N Vaishampayan Selected Research

Ulka N Vaishampayan Research Topics

Disease

26	Neoplasms (Cancer) 02/2022 - 12/2005
25	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 02/2007
17	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 12/2005
15	Carcinoma (Carcinomatosis) 12/2021 - 10/2005
13	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2006
6	Disease Progression 01/2021 - 07/2009
5	Urinary Bladder Neoplasms (Bladder Cancer) 12/2020 - 08/2015
3	Pain (Aches) 09/2014 - 07/2009
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2007
2	Fatigue 01/2017 - 09/2014
2	Nausea 01/2017 - 11/2007
2	Hand-Foot Syndrome 03/2016 - 07/2010
2	Kidney Neoplasms (Kidney Cancer) 01/2016 - 02/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2021
1	Adenocarcinoma 01/2021
1	Urologic Neoplasms (Urological Cancer) 10/2020
1	Clear-cell metastatic renal cell carcinoma 01/2020
1	Pathologic Complete Response 01/2019
1	Malignant Mesothelioma 01/2019
1	Mesothelioma 01/2019
1	Hemorrhage 11/2017
1	Limbal Stem Cell Deficiency 01/2017
1	Photophobia (Light Sensitivity) 01/2017

Drug/Important Bio-Agent (IBA)

10	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2005
8	PlatinumIBA 12/2021 - 10/2005
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 09/2012
5	AndrogensIBA 12/2021 - 04/2013
5	Everolimus FDA Link 10/2021 - 03/2016
5	Sunitinib (Sutent)FDA Link 10/2021 - 03/2016
4	Prostate-Specific Antigen (Semenogelase)IBA 12/2021 - 07/2009
4	cabozantinibIBA 01/2021 - 02/2013
4	Hormones (Hormone)IBA 01/2021 - 12/2005
3	enzalutamideIBA 10/2021 - 05/2015
3	olaparibIBA 03/2021 - 05/2017
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2021 - 05/2015
3	Bevacizumab (Avastin)FDA Link 12/2017 - 11/2013
3	Docetaxel (Taxotere)FDA Link 01/2014 - 07/2009
2	Abiraterone AcetateIBA 12/2021 - 11/2017
2	Androgen Receptors (Androgen Receptor)IBA 10/2021 - 05/2015
2	angiokinesIBA 06/2021 - 01/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 03/2016
2	AntigensIBA 01/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2018
2	Circulating Tumor DNAIBA 10/2020 - 01/2018
2	Cell-Free Nucleic AcidsIBA 10/2020 - 01/2018
2	IpilimumabIBA 12/2019 - 05/2017
2	NivolumabIBA 12/2019 - 05/2015
2	Therapeutic UsesIBA 10/2019 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2013
2	B7-H1 AntigenIBA 01/2017 - 02/2015
2	Gemcitabine FDA Link 08/2015 - 09/2014
2	Interleukin-2 (IL2)IBA 02/2015 - 11/2013
2	satraplatin (JM 216)IBA 01/2014 - 11/2009
2	InterferonsIBA 11/2007 - 02/2007
2	Thalidomide (Thalomid)FDA Link 11/2007 - 02/2007
1	trametinibIBA 02/2022
1	erdafitinibIBA 12/2021
1	antiarrhythmic peptide (AAP)IBA 12/2021
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 12/2021
1	Testosterone (Sustanon)FDA Link 12/2021
1	sacituzumab govitecanIBA 12/2021
1	enfortumab vedotinIBA 12/2021
1	Prednisone (Sone)FDA LinkGeneric 12/2021
1	GSK2636771IBA 10/2021
1	Recombinant DNA (Recombinant DNA Research)IBA 03/2021
1	ChromatinIBA 02/2021
1	cediranib (AZD2171)IBA 01/2021
1	bicalutamide (Casodex)FDA LinkGeneric 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	VaccinesIBA 01/2021
1	lenvatinibIBA 01/2021
1	LigandsIBA 01/2019
1	Pemetrexed (MTA)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	avelumabIBA 01/2019
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	carotuximabIBA 12/2017
1	clevudineIBA 12/2017
1	ThymineIBA 12/2017
1	Zoledronic Acid (Zometa)FDA Link 12/2017
1	Alanine Transaminase (SGPT)IBA 11/2017
1	Immune Checkpoint InhibitorsIBA 05/2017
1	Immunoconjugates (Immunoconjugate)IBA 01/2017
1	monomethylauristatin FIBA 01/2017
1	PF-06263507IBA 01/2017

Therapy/Procedure

34	Therapeutics 12/2021 - 10/2005
13	Drug Therapy (Chemotherapy) 12/2021 - 12/2005
6	Nephrectomy 11/2019 - 08/2006
4	Castration 10/2021 - 02/2013
4	Adjuvant Chemotherapy 12/2020 - 01/2018
3	Neoadjuvant Therapy 10/2020 - 08/2015
2	Radiotherapy 12/2021 - 05/2017
2	Cystectomy 12/2020 - 08/2015
1	Combination Drug Therapy (Combination Chemotherapy) 12/2021
1	Prostatectomy (Retropubic Prostatectomy) 12/2021
1	Immunotherapy 01/2021
1	Urinary Diversion (Ileal Conduit) 12/2020
1	Precision Medicine 05/2017